Free Trial

ImmunoPrecise Antibodies (IPA) SEC Filings & 10K Form

ImmunoPrecise Antibodies logo
$0.46 0.00 (-0.71%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.46 +0.01 (+1.29%)
As of 05/2/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ImmunoPrecise Antibodies SEC Filings

DateFilerForm TypeView
04/11/2025
12:43 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/09/2025
6:45 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2025
10:17 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/28/2025
9:48 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
8:43 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
7:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
8:54 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
11:29 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
9:00 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2025
12:58 PM
Charmquark TWEE (Filed by)
ImmunoPrecise Antibodies (Subject)
Form SCHEDULE 13G/A
01/22/2025
9:30 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/17/2025
10:30 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2025
9:20 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2024
8:03 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
7:36 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
7:37 AM
ImmunoPrecise Antibodies (Filer)
Form 20-F/A
12/10/2024
7:33 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
7:33 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
8:17 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:54 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
6:36 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
8:08 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
2:25 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
8:39 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2024
7:02 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
8:13 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
1:40 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
8:04 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
8:03 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
8:41 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:01 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
8:21 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/18/2024
11:15 PM
ImmunoPrecise Antibodies (Filer)
Form EFFECT
08/06/2024
4:16 PM
ImmunoPrecise Antibodies (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
07/30/2024
12:57 PM
ImmunoPrecise Antibodies (Filer)
Form D
Notice of Exempt Offering of Securities 
07/29/2024
7:35 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2024
7:38 AM
ImmunoPrecise Antibodies (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/23/2024
8:55 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
8:41 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
7:32 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
8:03 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)

A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.

Be ready before the historic gold move. Get Garrett’s Top Four picks now.
06/25/2024
8:12 AM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2024
12:01 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2024
1:23 PM
ImmunoPrecise Antibodies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IPA) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners